Exploratory Analysis of Coagulation and Fibrinolysis Trajectories After IL-6 Antagonist Therapy in COVID-19: A Case Series.

Biomedicines · 2026 · PMC12838625 · PMID 41595788

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

nominally significantno p-value reported

Primary Outcomes Paired Wilcoxon analyses revealed nominally significant changes in four parameters: ECA-test LOT (T0 vs.

also in 7,732 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.